Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 144 for “"partial agonist"”.

  1. Effects of Trace Amine-Associated Receptor 1 Partial Agonist RO5263397 on Morphine-Related Behaviors

    … investigated the effects of a selective TAAR1 partial agonist RO5263397 on morphine-related behaviors. We found that RO5263397 attenuated morphine-intake in morphine self-administration model and decreased the breakpoint under progressive-ratio schedule of responding. RO5263397 did not affect …

    buffalo Repository record for Effects of Trace Amine-Associated Receptor 1 Partial Agonist RO5263397 on Morphine-Related Behaviors (opens in a new tab)

  2. Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia

    … silence the positive symptoms due to antagonistic actions on dopamine D2 receptors. Unfortunately, the APDs are associated with aversive side effects and there is still severe paucity in the treatment of negative symptoms and cognitive impairments. 2-Bromoterguride (2BT) is a dopamine D2 …

    fu-berlin Repository record for Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia (opens in a new tab)

  3. Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia

    … silence the positive symptoms due to antagonistic actions on dopamine D2 receptors. Unfortunately, the APDs are associated with aversive side effects and there is still severe paucity in the treatment of negative symptoms and cognitive impairments. 2-Bromoterguride (2BT) is a dopamine D2 …

    fu-berlin Repository record for Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia (opens in a new tab)

  4. Examining the Inhibition Mechanism of EPAC

    A novel partial agonist of the exchange protein activated by cAMP isoform 1 (EPAC1), I942, was recently discovered and shown to reduce the guanine exchange factor activity of cAMP-bound EPAC1 to approximately 10% relative to cAMP activation. However, the inhibition mechanism of I942 remains …

    mcmaster Repository record for Examining the Inhibition Mechanism of EPAC (opens in a new tab)

  5. T-cell signaling in response to altered myelin basic protein peptides

    … with MBP protein. A number of peptides with antagonist or partial agonist activities were identified. A hierarchy of activities was defined based on the ability of a peptide to induce early signaling, proliferation, cytokine production, and antagonism. In addition, a more extensive study of …

    washington Repository record for T-cell signaling in response to altered myelin basic protein peptides (opens in a new tab)

  6. The relationship between glycine receptor agonist efficacy and allosteric modulation

    … the brain and spinal cord. Both glycine and the partial agonist taurine act as endogenous ligands of the GlyR. Taurine-activated GlyR may have a role in the rewarding effects of drugs of abuse, such as ethanol. As a partial agonist, taurine has a decreased efficacy relative to glycine, resulting …

    texas Repository record for The relationship between glycine receptor agonist efficacy and allosteric modulation (opens in a new tab)

  7. Investigating the pharmacology of novel 5-HT3 receptor ligands; with the potential to treat neuropsychiatric and gastrointestinal disorders

    … heteromeric 5-HT3AB receptor. 5-HT3 receptor antagonists are used clinically to treat chemotherapy induced and post-operative nausea and vomiting, and demonstrate symptomatic relief in diarrhoea-predominant irritable bowel syndrome (IBS-d); but unfortunately, these medications cause adverse …

    birmingham Download PDF for Investigating the pharmacology of novel 5-HT3 receptor ligands; with the potential to treat neuropsychiatric and gastrointestinal disorders (opens in a new tab)

  8. Molecular pharmacological studies of the muscarinic receptors and the creatine transporter

    … be a functional selective M1 muscarinic receptor partial agonist. (-)YM796 stimulated [³H] IP₁ ([³H] inositol-1-phosphate) accumulation in LK3-3 cells without significant inhibition of the cAMP formation in M2LKB2-2 cells up to 1mM. (+)YM796 exhibited no significant efficacy for the M1 and M2 …

    arizona-thes Repository record for Molecular pharmacological studies of the muscarinic receptors and the creatine transporter (opens in a new tab)

  9. Efeito de ligantes do receptor da nociceptina/orfanina FQ no comportamento agressivo de camundongos machos

    … NOP ligands Ro 65-6570 (0.01 – 1 mg/kg), full agonist, AT-090 (0,01 – 0,1 mg/kg), partial agonist, and SB-612111 (1 – 10 mg/kg), antagonist, were used. In the resident-intruder test, male mice were housed individually for 7 days (residents) before the experiment. The aggressiveness of each …

    brazil-ufrn Repository record for Efeito de ligantes do receptor da nociceptina/orfanina FQ no comportamento agressivo de camundongos machos (opens in a new tab)

  10. STRUCTURAL-GUIDED MODIFIED INDOLYLPYRIMIDYLPIPERAZINES SYNTHESIS FOR GASTROINTESTINAL CANCER THERAPY

    … patients with adenosine A3-selective full agonists, IB-MECA and 2Cl-IN-MECA, showed marked improvement in the patients’ medical conditions. However, in vitro studies have also confirmed that the application of these adenosine A3-selective full agonists lead to rapid receptor trafficking and …

    nus Repository record for STRUCTURAL-GUIDED MODIFIED INDOLYLPYRIMIDYLPIPERAZINES SYNTHESIS FOR GASTROINTESTINAL CANCER THERAPY (opens in a new tab) Download file for STRUCTURAL-GUIDED MODIFIED INDOLYLPYRIMIDYLPIPERAZINES SYNTHESIS FOR GASTROINTESTINAL CANCER THERAPY (opens in a new tab)

  11. NUOVI LIGANDI DEI RECETTORI NICOTINICI NEURONALI: BENZODIOSSANI E PIRIDODIOSSANI 2-PIRROLIDINIL SOSTITUITI

    … 7-hydroxy derivative was proved to be a potent partial agonist at the 42 and 62 receptors. Other 7-substituted pyrrolidinyl-benzodioxanes are under biological evaluation as well as the pyrrolidinyl-pyridodioxane stereoisomers. High 42 affinity was found for the SS stereoisomer of the …

    milano Repository record for NUOVI LIGANDI DEI RECETTORI NICOTINICI NEURONALI: BENZODIOSSANI E PIRIDODIOSSANI 2-PIRROLIDINIL SOSTITUITI (opens in a new tab) Restricted access

  12. Novel Analogs of m-Chlorophenylguanidine as 5-HT3 Receptor Ligands

    … addiction, and satiety control. A 5-HT3 receptor partial agonist, MD-354, served as a lead compound in the development of new 5-HT3 receptor ligands. Using halogenated analogs the study investigated their effect on binding to the 5-HT3 receptor. Conformationally-constrained analogs (quinazolines) …

    vcu Repository record for Novel Analogs of m-Chlorophenylguanidine as 5-HT3 Receptor Ligands (opens in a new tab)

  13. SUBTYPE-SELECTIVE NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS AND ANTAGONISTS

    … is the design and synthesis of α4β2 selective partial agonists as potential smoking-cessation agents. The aim of the second part is the design and synthesis of α7 antagonists with mitocan properties as antitumoral agents. Part 1. In the first project, a series of 3-nitrophenyl ethers and …

    milano Repository record for SUBTYPE-SELECTIVE NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS AND ANTAGONISTS (opens in a new tab)

  14. FXR AGONISTS INDUCE DISTINCT H-12 STRUCTURAL STATES

    … While the coregulator surface of apo FXR and partial-agonist bound FXR exchanges between multiple low energy conformations, full-agonist bound FXR is restricted to few conformations, which favor coactivator binding. Furthermore, we find that two ligands that induce similar affinities for a …

    montana Repository record for FXR AGONISTS INDUCE DISTINCT H-12 STRUCTURAL STATES (opens in a new tab)

  15. FXR AGONISTS INDUCE DISTINCT H-12 STRUCTURAL STATES

    … While the coregulator surface of apo FXR and partial-agonist bound FXR exchanges between multiple low energy conformations, full-agonist bound FXR is restricted to few conformations, which favor coactivator binding. Furthermore, we find that two ligands that induce similar affinities for a …

    montana-tech Repository record for FXR AGONISTS INDUCE DISTINCT H-12 STRUCTURAL STATES (opens in a new tab)

  16. Effects of progesterone receptor modulators on human endometrium

    … conditions. Asoprisnil is a PRM with partial agonist and antagonist properties and is the most clinically advanced compound in its group. It has been shown to have an endometrial antiproliferative effect in non-human primates and humans and as such to cause reversible amenorrhoea. This …

    edinburgh Repository record for Effects of progesterone receptor modulators on human endometrium (opens in a new tab)

  17. The structural selectivity and various ligands of PPAR gamma

    … full agonism of PPARγ may cause side effects and partial agonism of PPARγ could potentially provide the same benefits as full agonism of PPAR. Individuals also seem to respond differently to PPAR agonists. In this thesis, we characterised various ligands in hopes of creating a PPAR targeting …

    adelaide Repository record for The structural selectivity and various ligands of PPAR gamma (opens in a new tab)

  18. The binding and activation of the glucagon-like peptide-1 receptor by exendin-4

    … loss of affinity; furthermore, GLP-1(15-36) is a partial agonist while EX4(9-39) is an antagonist. Previous binding analysis of either N or C-terminally truncated EX4 at rGLP-1R suggested that the residues responsible for its extra affinity are at its C-terminus, EX4 residues 31-39. Crystal …

    whiterose Download PDF for The binding and activation of the glucagon-like peptide-1 receptor by exendin-4 (opens in a new tab)

Page 1 of 8